≥99% HPLCPre-filled pen

BPC-157 (Body Protection Compound-157)

Name: BPC-157 (Body Protection Compound-157)
Brand: Dripfy
Availability: InStock

What it is?

BPC-157 is a peptide derived from gastric tissue, widely studied for its protective and regenerative signalling across multiple tissue systems. It is commonly positioned for connective tissue recovery and gastrointestinal barrier support pathways.

Dripfy Advantage

Growth-factor signalling support: Associated with upregulation of repair-related growth-factor pathways in tissue regeneration models.
Angiogenesis & perfusion pathways: Supports vascular signalling that may improve tissue perfusion during recovery processes.
Collagen and ECM remodelling: Positioned for collagen-related signalling and extracellular matrix (ECM) restructuring, key in tendon and ligament repair.
Inflammation balance: May modulate inflammatory pathways to support a more optimal healing microenvironment.
GI barrier protection: Frequently studied for supporting gut lining integrity and mucosal recovery markers.

Clinical Applications & Therapeutic Potential

Musculoskeletal repair: Positioned for recovery endpoints in muscles, tendons, ligaments, and joints, particularly in slow-healing connective tissue models.
Pain / inflammation-associated markers: Potential support for reduced inflammation signalling and improved discomfort-related outcomes.
Gastrointestinal recovery: Potential support for mucosal integrity, gut barrier function, and GI repair dynamics.
Wound healing pathways: Associated with repair signalling relevant to wound healing and tissue remodelling models.

Composition & Formulation

Peptide content: 5 mg BPC-157
Vehicle: Proprietary pH-balanced buffer solution
Delivery system: Pre-filled, multi-dose, closed-system pen
Total volume: 3 mL
Purity: ≥99% by HPLC/MS

€499

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

BPC-157 (Body Protection Compound-157)

Investigational synthetic gastric-derived peptide (regenerative / cytoprotective) · Pre-filled pen

D· Preliminary evidence

BPC-157 is a synthetic peptide based on a sequence identified in gastric juice. In animal and cell studies it is associated with upregulation of repair-related growth-factor and angiogenic signalling (for example VEGF-linked pathways), collagen and extracellular-matrix (ECM) remodelling, and modulation of inflammation, which underlies research interest in connective-tissue and gut-lining recovery. Well-controlled human evidence remains very limited.

Studied use areas

Tendon, ligament and musculoskeletal recovery (research context)
Gastrointestinal barrier and mucosal integrity (research context)
Wound-healing and tissue-perfusion signalling
Angiogenesis and local circulation during recovery
Inflammation balance in the healing microenvironment

Safety & status

Investigational and not an approved medicine; robust human safety data are lacking
Prohibited in competitive sport under the WADA non-approved-substance category
Product purity and source quality can vary and affect risk
Use only under qualified physician oversight

⚕ Clinical note: This card is educational and is not medical advice. BPC-157 is investigational; any use must be individualised and determined by the treating physician.

Evidence: Investigational — mainly animal and cell data; no approved human indication · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings